26 results
IBD Colonoscopy Surveillance - BSG Guidelines 2019
High Risk - 1 Year
 •  Extensive colitis AND
IBD Colonoscopy ... Surveillance - BSG Guidelines ... 2019 High Risk - 1 ... #BSG #Guidelines ... #management
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... Epidemiology: • #1 ... 10 mg/kg IV x 1 ... IDSA 2021 CDI ... Treatment Guideline
Pelvic Inflammatory Disease (PID) - CDC 2021 Treatment Guidelines
Recommended Regimen:
 • Parenteral treatment: ceftriaxone 1 gm
(PID) - CDC 2021 ... Treatment Guidelines ... : ceftriaxone 1 ... #Treatment #Guidelines ... #Management #STI
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
IDSA Recommendations ... Infection General Management ... IsosporaBelli #IDSA ... #Prevention #Treatment ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 400 mg PO BID ... 4–6 mL QID or 1– ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... • Valacyclovir 1 ... • Valacyclovir 1 ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... patients with CD4 ... #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #management #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... mg/kg on days 1– ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
IDSA Recommendations ... Prevention and Treatment ... daily or 50 mg PO BID ... opportunistic #infections #HIVAIDS ... #management #pharmacology